Overall, the researchers estimated that GLP-1 use was associated with 12 fewer serious addiction-related events per 1,000 users
Both agents demonstrate favorable effects on cardiovascular risk factors, including blood pressure reduction and lipid profile improvement
In the natural aging + FOXO4-DRI group, mice received intraperitoneal injections of FOXO4-DRI (5 mg/kg, MCE, HY-P4157) every 2 days during the same period, followed by tissue collection
The effects of GLP-1 agonists on MASH may be indirect, resulting from reductions in calorie intake, body weight, and insulin resistance, all of which help decrease liver lipid accumulation and hepatic inflammation
J Diabetes novembre
These typically decrease as ones body adjusts to the medicine and through careful dosing escalation of Exenate